SynthesisReviews in medical virology2022

Comprehensive adjusted outcome data are needed to assess the impact of immune checkpoint inhibitors in cancer patients with COVID-19: Results of a systematic review and meta-analysis.

Samuel J Minkove et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.